MTR4 Antibody - #DF7409
製品: | MTR4 Antibody |
カタログ: | DF7409 |
タンパク質の説明: | Rabbit polyclonal antibody to MTR4 |
アプリケーション: | WB IHC |
反応性: | Human, Mouse, Rat |
予測: | Pig, Bovine, Chicken |
分子量: | 118kDa; 118kD(Calculated). |
ユニプロット: | P42285 |
RRID: | AB_2839347 |
製品説明
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
引用形式: Affinity Biosciences Cat# DF7409, RRID:AB_2839347.
折りたたみ/展開
2610528A15Rik; ATP dependent helicase SKIV2L2; Dob1; KIAA0052; MGC142069; mKIAA0052; Mtr4; superkiller viralicidic activity 2 like 2 (S. cerevisiae); Superkiller viralicidic activity 2 like 2;
免疫原
- P42285 MTREX_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MADAFGDELFSVFEGDSTTAAGTKKDKEKDKGKWKGPPGSADKAGKRFDGKLQSESTNNGKNKRDVDFEGTDEPIFGKKPRIEESITEDLSLADLMPRVKVQSVETVEGCTHEVALPAEEDYLPLKPRVGKAAKEYPFILDAFQREAIQCVDNNQSVLVSAHTSAGKTVCAEYAIALALREKQRVIFTSPIKALSNQKYREMYEEFQDVGLMTGDVTINPTASCLVMTTEILRSMLYRGSEVMREVAWVIFDEIHYMRDSERGVVWEETIILLPDNVHYVFLSATIPNARQFAEWICHLHKQPCHVIYTDYRPTPLQHYIFPAGGDGLHLVVDENGDFREDNFNTAMQVLRDAGDLAKGDQKGRKGGTKGPSNVFKIVKMIMERNFQPVIIFSFSKKDCEAYALQMTKLDFNTDEEKKMVEEVFSNAIDCLSDEDKKLPQVEHVLPLLKRGIGIHHGGLLPILKETIEILFSEGLIKALFATETFAMGINMPARTVLFTNARKFDGKDFRWISSGEYIQMSGRAGRRGMDDRGIVILMVDEKMSPTIGKQLLKGSADPLNSAFHLTYNMVLNLLRVEEINPEYMLEKSFYQFQHYRAIPGVVEKVKNSEEQYNKIVIPNEESVVIYYKIRQQLAKLGKEIEEYIHKPKYCLPFLQPGRLVKVKNEGDDFGWGVVVNFSKKSNVKPNSGELDPLYVVEVLLRCSKESLKNSATEAAKPAKPDEKGEMQVVPVLVHLLSAISSVRLYIPKDLRPVDNRQSVLKSIQEVQKRFPDGIPLLDPIDDMGIQDQGLKKVIQKVEAFEHRMYSHPLHNDPNLETVYTLCEKKAQIAIDIKSAKRELKKARTVLQMDELKCRKRVLRRLGFATSSDVIEMKGRVACEISSADELLLTEMMFNGLFNDLSAEQATALLSCFVFQENSSEMPKLTEQLAGPLRQMQECAKRIAKVSAEAKLEIDEETYLSSFKPHLMDVVYTWATGATFAHICKMTDVFEGSIIRCMRRLEELLRQMCQAAKAIGNTELENKFAEGITKIKRDIVFAASLYL
種類予測
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - P42285 基板として
Site | PTM Type | Enzyme | Source |
---|---|---|---|
A2 | Acetylation | Uniprot | |
S40 | Phosphorylation | Uniprot | |
K43 | Acetylation | Uniprot | |
K51 | Acetylation | Uniprot | |
K78 | Acetylation | Uniprot | |
K78 | Ubiquitination | Uniprot | |
S85 | Phosphorylation | Uniprot | |
K126 | Ubiquitination | Uniprot | |
K134 | Ubiquitination | Uniprot | |
Y136 | Phosphorylation | Uniprot | |
T188 | Phosphorylation | Uniprot | |
S189 | Phosphorylation | Uniprot | |
K192 | Ubiquitination | Uniprot | |
K198 | Acetylation | Uniprot | |
S234 | Phosphorylation | Uniprot | |
S240 | Phosphorylation | Uniprot | |
T269 | Phosphorylation | Uniprot | |
K358 | Ubiquitination | Uniprot | |
K369 | Ubiquitination | Uniprot | |
K379 | Acetylation | Uniprot | |
K379 | Ubiquitination | Uniprot | |
K396 | Acetylation | Uniprot | |
K397 | Ubiquitination | Uniprot | |
Y402 | Phosphorylation | Uniprot | |
T407 | Phosphorylation | Uniprot | |
K408 | Ubiquitination | Uniprot | |
T413 | Phosphorylation | Uniprot | |
K417 | Ubiquitination | Uniprot | |
T466 | Phosphorylation | Uniprot | |
S472 | Phosphorylation | Uniprot | |
T499 | Phosphorylation | Uniprot | |
K503 | Ubiquitination | Uniprot | |
K507 | Ubiquitination | Uniprot | |
Y517 | Phosphorylation | Uniprot | |
K549 | Ubiquitination | Uniprot | |
Y583 | Phosphorylation | Uniprot | |
K587 | Ubiquitination | Uniprot | |
Y590 | Phosphorylation | Uniprot | |
K614 | Ubiquitination | Uniprot | |
K638 | Ubiquitination | Uniprot | |
K646 | Ubiquitination | Uniprot | |
S687 | Phosphorylation | Uniprot | |
Y694 | Phosphorylation | Uniprot | |
K748 | Acetylation | Uniprot | |
K748 | Ubiquitination | Uniprot | |
K761 | Ubiquitination | Uniprot | |
K768 | Ubiquitination | Uniprot | |
K792 | Acetylation | Uniprot | |
K796 | Acetylation | Uniprot | |
K796 | Ubiquitination | Uniprot | |
T844 | Phosphorylation | Uniprot | |
K852 | Ubiquitination | Uniprot | |
K873 | Ubiquitination | Uniprot | |
K1022 | Ubiquitination | Uniprot |
研究背景
Catalyzes the ATP-dependent unwinding of RNA duplexes with a single-stranded 3' RNA extension. Central subunit of many protein complexes, namely TRAMP-like, nuclear exosome targeting (NEXT) and poly(A) tail exosome targeting (PAXT). NEXT functions as an RNA exosome cofactor that directs a subset of non-coding short-lived RNAs for exosomal degradation. NEXT is involved in surveillance and turnover of aberrant transcripts and non-coding RNAs. PAXT directs a subset of long and polyadenylated poly(A) RNAs for exosomal degradation. The RNA exosome is fundamental for the degradation of RNA in eukaryotic nuclei. Substrate targeting is facilitated by its cofactor ZCCHC8, which links to RNA-binding protein adapters. Associated with the RNA exosome complex and involved in the 3'-processing of the 7S pre-RNA to the mature 5.8S rRNA. May be involved in pre-mRNA splicing. In the context of NEXT complex can also in vitro unwind DNA:RNA heteroduplexes with a 3' poly (A) RNA tracking strand. Can promote unwinding and degradation of structured RNA substrates when associated with the nuclear exosome and its cofactors. Can displace a DNA strand while translocating on RNA to ultimately degrade the RNA within a DNA/RNA heteroduplex.
Nucleus>Nucleoplasm. Nucleus>Nucleolus. Nucleus. Nucleus speckle.
Component of a TRAMP-like complex, an ATP-dependent exosome regulatory complex consisting of a helicase (MTREX), an oligadenylate polymerase (TENT4B or TENT4A), and a substrate specific RNA-binding factor (ZCCHC7 or ZCCHC8). Several TRAMP-like complexes exist with specific compositions and are associated with nuclear, or nucleolar RNA exosomes. Identified in the spliceosome C complex. Component of the poly(A) tail exosome targeting (PAXT) complex made of PABPN1, ZFC3H1 and MTREX that directs a subset of long and polyadenylated poly(A) RNAs for exosomal degradation. Component of the nuclear exosome targeting (NEXT) complex composed of MTREX, ZCCHC8, and RBM7 that directs a subset of non-coding short-lived RNAs for exosomal degradation. Interacts with ZCCHC8; this interaction bridges the interaction between RBM7 and MTREX. Binds to ZFC3H1 and RBM7 in a RNase-insensitive manner. Interacts with EXOSC10; the interaction mediates the association of MTREX with nuclear RNA exosomes. Interacts with isoform 1 of NVL in an ATP-dependent manner; the interaction is required to associate NVL with nuclear RNA exosome. Interacts with WDR74; the interaction dissociation in a late stage of rRNA synthesis is required for appropriate maturation of pre-60S particles and depends on the ATPase activity of NVL. Interacts with MPHOSPH6. Interacts with the RNA cap-binding complex proteins NCBP1 and SRRT. Interacts with NRDE2; the interaction is direct and negatively regulates MTREX function in exosomal degradation by changing its conformation precluding interaction with ZFC3H1, the RNA cap-binding complex proteins NCBP1 and SRRT, and association with the exosome. Interacts with the nuclear RNA exosome complex.
Belongs to the helicase family. SKI2 subfamily.
研究領域
· Genetic Information Processing > Folding, sorting and degradation > RNA degradation.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.